Chinese IPOs in US falter amid scrutiny of manipulation schemes
Regulators crack down after trading in ‘toxic’ small-cap stocks from China inflicted losses on US investors
Regulators crack down after trading in ‘toxic’ small-cap stocks from China inflicted losses on US investors

Regulator targets some opaque ‘red-chip’ structures but signals the market for new issues is still open

A handful of Nasdaq-listed Chinese companies crashed last month after heavy promotion on social media

The US needs more public listings but the regulatory pendulum may be swinging too far

Institutional clients increasingly want so-called parallel funds that exclude certain assets

Fear of national security risks and investor protections spurs rare bipartisan call for action from financial regulator

Technology-heavy exchange has grappled with rise in volatile trading related to US-listed Chinese companies